Drug diversion and compliance experts join ANiGENT’s Board of Advisors

St. Louis, Tuesday, August 4, 2020 — Three drug diversion prevention influencers — Pamela Mergens, M.D.; Simone Cummings, M.H.A., Ph.D.; and global life sciences executive Neal Long — have recently joined ANiGENT’s Board of Advisors (BOA). They will provide insights that will help the company identify and fine tune the future drivers of growth to accelerate ANiGENT’s success.
VIEW THE ENTIRE PRESS RELEASE >>>

–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––

DYNALABS joins forces with Mayo Clinic to help hospitals prevent medication diversion.

ST. LOUIS, March 24, 2020 /PRNewswire/ — DYNALABS and Mayo Clinic have joined forces to launch ANiGENT, a new company whose proprietary software uses machine learning to deliver a state-of-the-art drug diversion surveillance system. The novel platform will help hospitals and health systems reduce patient and worker harm from potential drug diversion and prevent regulatory or legal risk. The collaboration unites the clinical expertise of Mayo Clinic with analytic lab testing company DYNALABS, which offers an industry-leading technology.
VIEW ENTIRE PRESS RELEASE >>>

–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––

FOR ADDITIONAL INFORMATION, CALL
Marita Gomez, 630-936-9105
maritag@crispsolution.net